Nom du produit:(S)-4-(tert-Butoxycarbonyl)-1,4-oxazepane-2-carboxylic acid

IUPAC Name:(2S)-4-[(tert-butoxy)carbonyl]-1,4-oxazepane-2-carboxylic acid

CAS:1273567-44-4
Formule moléculaire:C11H19NO5
Pureté:95%
Numéro de catalogue:CM284795
Poids moléculaire:245.28

Unité d'emballage Stock disponible Prix($) Quantité
CM284795-1g in stock ũũƎ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1273567-44-4
Formule moléculaire:C11H19NO5
Point de fusion:-
Code SMILES:O=C([C@H]1OCCCN(C(OC(C)(C)C)=O)C1)O
Densité:
Numéro de catalogue:CM284795
Poids moléculaire:245.28
Point d'ébullition:384.0±42.0°C at 760 mmHg
N° Mdl:MFCD19442252
Stockage:Store at 2-8°C.

Column Infos

Brensocatib
May 28 2024, Insmed announced positive topline results from landmark ASPEN study of Brensocatib in patients with bronchiectasis.
Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1) being developed for the treatment of patients with bronchiectasis, CRSsNP, and other neutrophil-mediated diseases. DPP1 is an enzyme responsible for activating neutrophil serine proteases (NSPs), such as neutrophil elastase, in neutrophils when they are formed in the bone marrow. Brensocatib is an investigational drug product that has not been approved for any indication in any jurisdiction.

Related Products